MedTrace Logo

High Definition Medicine for Solid Tumors Oncology

NCT06590506 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-09-19

No results posted yet for this study

Summary

The present study aims to analyze different genetic, phenotypic, environmental, social and lifestyle characteristics of cancer patients who are going to start a first line of cancer treatment with palliative intent and their possible relationship with tumor response or tolerance to treatment. In this way, the aim is to identify a series of variables that allow a better selection of patients and oncological treatments.

Conditions

Interventions

DEVICE

Wearable

Continuous monitoring thought data recorded with wearable (Vivosmart Garmin bracelet)

Sponsors & Collaborators

  • Centro Nacional de Investigaciones Oncologicas CARLOS III

    lead OTHER

Principal Investigators

  • Miguel A Quintela, PhD · CNIO- Spanish Research Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-02
Primary Completion
2026-01-30
Completion
2028-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06590506 on ClinicalTrials.gov